Cargando…

The Combined Effect of Oseltamivir and Favipiravir on Influenza A Virus Evolution

Influenza virus inflicts a heavy death toll annually and resistance to existing antiviral drugs has generated interest in the development of agents with novel mechanisms of action. Favipiravir is an antiviral drug that acts by increasing the genome-wide mutation rate of influenza A virus (IAV). Pote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ormond, Louise, Liu, Ping, Matuszewski, Sebastian, Renzette, Nicholas, Bank, Claudia, Zeldovich, Konstantin, Bolon, Daniel N., Kowalik, Timothy F., Finberg, Robert W., Jensen, Jeffrey D., Wang, Jennifer P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570085/ https://www.ncbi.nlm.nih.gov/pubmed/28854600 http://dx.doi.org/10.1093/gbe/evx138

Ejemplares similares

Influenza Virus Drug Resistance: A Time-Sampled Population Genetics Perspective
por: Foll, Matthieu, et al.
Publicado: (2014)

Two sides of the same coin: A population genetics perspective on lethal mutagenesis and mutational meltdown
por: Matuszewski, Sebastian, et al.
Publicado: (2017)

Rapid Intrahost Evolution of Human Cytomegalovirus Is Shaped by Demography and Positive Selection
por: Renzette, Nicholas, et al.
Publicado: (2013)

Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus
por: Baz, Mariana, et al.
Publicado: (2018)

Antiviral drug resistance as an adaptive process
por: Irwin, Kristen K., et al.
Publicado: (2016)

Extensive Genome-Wide Variability of Human Cytomegalovirus in Congenitally Infected Infants
por: Renzette, Nicholas, et al.
Publicado: (2011)

Combination Effects of Peramivir and Favipiravir against Oseltamivir-Resistant 2009 Pandemic Influenza A(H1N1) Infection in Mice
por: Park, Sehee, et al.
Publicado: (2014)

Favipiravir/hydroxychloroquine/oseltamivir: Tonic clonic seizures following off label use: case report
Publicado: (2020)

Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
por: Wang, Yeming, et al.
Publicado: (2020)

The mechanism of resistance to favipiravir in influenza
por: Goldhill, Daniel H., et al.
Publicado: (2018)

The Adaptive Potential of the Middle Domain of Yeast Hsp90
por: Cote-Hammarlof, Pamela A, et al.
Publicado: (2020)

Oseltamivir in human avian influenza infection
por: Smith, James R.
Publicado: (2010)

Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
por: Chan, Renee W. Y., et al.
Publicado: (2022)

Efficacy comparison of oseltamivir alone and oseltamivir-antibiotic combination for early resolution of symptoms of severe influenza-A and influenza-B hospitalized patients
por: Ishaqui, Azfar A., et al.
Publicado: (2020)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non‐obese volunteers
por: Chairat, Kalayanee, et al.
Publicado: (2016)

A Bayesian MCMC Approach to Assess the Complete Distribution of Fitness Effects of New Mutations: Uncovering the Potential for Adaptive Walks in Challenging Environments
por: Bank, Claudia, et al.
Publicado: (2014)

Adherence to Oseltamivir Guidelines during Influenza Pandemic, the Netherlands
por: Fietjé, Esther H., et al.
Publicado: (2012)

Oseltamivir resistance in swine influenza: a brief discussion
por: Wiwanitkit, Viroj
Publicado: (2009)

Oseltamivir use amongst hospitalized patients infected with influenza
por: Herman, Michael, et al.
Publicado: (2014)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
por: Hurt, Aeron C., et al.
Publicado: (2016)

Oseltamivir treatment of influenza A and B infections in infants
por: Mattila, Janna‐Maija, et al.
Publicado: (2021)

Evaluation of the Clinical Effectiveness of Oseltamivir for Influenza Treatment in Children
por: Qin, Jianru, et al.
Publicado: (2022)

Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study
por: Zhang, Yan, et al.
Publicado: (2016)

2645. Clinical Outcomes of Oseltamivir vs. Baloxavir in Patients Hospitalized with Influenza A
por: Shah, Sunish, et al.
Publicado: (2019)

Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19
por: Ison, Michael G., et al.
Publicado: (2021)

Favipiravir-resistant influenza A virus shows potential for transmission
por: Goldhill, Daniel H., et al.
Publicado: (2021)

Comparison of efficacy and safety of oseltamivir and zanamivir in pandemic influenza treatment
por: Tuna, Nazan, et al.
Publicado: (2012)

1715 Oseltamivir use in an Influenza Outbreak: Linking Pharmacology to Pharmacoeconomics
por: Chaiyakunapruk, Nathorn, et al.
Publicado: (2014)

Effectiveness of Oseltamivir Prophylaxis in Influenza Outbreaks in Residential Aged Care
por: Dronavalli, Mithilesh, et al.
Publicado: (2020)

Maternal and Perinatal Outcomes of Influenza in Pregnancy after Treatment with Oseltamivir
por: Abraham, Kavitha, et al.
Publicado: (2021)

Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
por: Medaglia, Chiara, et al.
Publicado: (2021)

Efficacy of oseltamivir treatment in influenza virus-infected obese mice
por: Honce, Rebekah, et al.
Publicado: (2023)

Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007–08
por: Hauge, Siri H, et al.
Publicado: (2009)

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers
por: Jang, Kyungho, et al.
Publicado: (2017)

Latent Effects of Hsp90 Mutants Revealed at Reduced Expression Levels
por: Jiang, Li, et al.
Publicado: (2013)

Reduced Sensitivity of Influenza A (H5N1) to Oseltamivir
por: McKimm-Breschkin, Jennifer L., et al.
Publicado: (2007)

Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients
por: Dutkowski, Regina
Publicado: (2010)

Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations
por: Davies, Brian E.
Publicado: (2010)

Simultaneous Detection of Oseltamivir- and Amantadine-Resistant Influenza by Oligonucleotide Microarray Visualization
por: Zhang, Yingjie, et al.
Publicado: (2013)

Oseltamivir Expands Quasispecies of Influenza Virus through Cell-to-cell Transmission
por: Mori, Kotaro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fuaukg7rh14casf6q49214hjp4